Bhartiya International designs and manufactures leather apparel and accessories for global fashion brands, operating a vertically integrated supply chain from tanning to finished garments.
The company lacks a durable moat as evidenced by an average ROCE of 7.7%, which is below the typical cost of capital. While they have long-standing relationships with global retailers, the low net margins of 2.1% indicate they operate as a price-taking contract manufacturer in a highly competitive global market.
Management has reinvested in tanneries and SEZ developments, but these have yet to yield high returns, with several subsidiaries reporting persistent losses. Recent capital raising via warrants was used primarily for working capital and factory refurbishment rather than high-return growth initiatives.
The company's thin margins were eventually crushed by a combination of rising interest rates and a cyclical downturn in global retail demand. Because the business operated with high leverage and an interest coverage ratio barely above one, the lack of a pricing cushion led to a liquidity crunch. Capital that should have buffered the downturn was instead trapped in underperforming subsidiaries and real estate ventures, forcing dilutive equity raises at the bottom of the cycle to keep the lights on, permanently impairing shareholder value.
RichFakir rates Bhartiya International Ltd's business quality as poor — 34/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Bhartiya International Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Bhartiya International Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Bhartiya International Ltd's fair value is about ₹351 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →